UBS Group’s Cartesian Growth Corporation II Unit RENEU Stock Holding History

UBS Group’s Portfolio RENEU Stock Details RENEU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20	Closed	-$222	–	10524
2024 Q2	$222	Hold	20	–	–	﹤0.01%	9064
2024 Q1	$222	Buy	+20	New	+$222	﹤0.01%	8722
2023 Q1	–	Sell	-840	Closed	-$8.59K	–	11565
2022 Q4	$8.59K	Hold	840	–	–	﹤0.01%	8756
2022 Q3	$8K	Sell	840 -367	-30%	-$3.68K	﹤0.01%	8826
2022 Q2	$12K	Buy	+1,207	New	+$12.1K	﹤0.01%	7756

Other funds holding RENEU

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group's RENEU Position: Q3 2024 in Review

UBS Group sold out of Cartesian Growth Corporation II Unit (RENEU) in Q3 2024, closing a stake of 20 shares — an estimated $222 sold.

UBS Group first reported a position in RENEU in Q2 2022 and held it in 5 quarters. The position peaked at $12K in Q2 2022. 1 fund tracked by Wall St. Rank holds RENEU as of Q3 2024.

UBS Group reported no remaining Cartesian Growth Corporation II Unit position as of Q3 2024 after selling out during the quarter.
UBS Group sold 20 Cartesian Growth Corporation II Unit shares in Q3 2024, an estimated $222.
UBS Group first reported a position in Cartesian Growth Corporation II Unit in Q2 2022 and held it in 5 quarters.
UBS Group's Cartesian Growth Corporation II Unit position peaked at $12K in Q2 2022.
1 fund tracked by Wall St. Rank held Cartesian Growth Corporation II Unit as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.